North Life Pharma has continued its success in 2019, consolidating its presence in the Peruvian and Bolivian markets while ceasing its supplies to Venezuela. This decision is part of the company’s focus on optimising its operations in key markets across Latin America.
In a major step forward, North Life Pharma has established a local subsidiary in Ecuador. This new entity will manage the distribution of its products both to private sector customers and the public healthcare market within the country, enhancing the company’s footprint in the region and ensuring more efficient delivery of essential medicines.
A key growth driver this year has been the company’s expansion of its portfolio of antiretroviral products, such as Raltegravir. Additionally, North Life Pharma has bolstered its offerings of specialized antibiotics, further strengthening its position as a trusted pharmaceutical supplier to the Peruvian and Bolivian market.
Looking ahead, North Life Pharma remains committed to expanding both its product range and the number of countries it serves, continuing to fulfil its mission of providing high-quality, affordable healthcare solutions to developing markets worldwide. With a focus on innovation and strategic growth, the company is well-positioned for further success in the coming years.